Skip to content

CaenenRx

Active
Private limited companyfounded 20251 yr activeGuldenspoorstraat 5, 9000 Gent, BelgiumKBO/BCE: BE 1018.427.348
Summary

CaenenRx has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,851 and a net result of €27,684. Its solvency ranks better than 34% of 7814 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
Axes
Profitability100
Solvency54
Growth-
Track record67
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000 at 30 days acceptable
Liquidity tight (current ratio 1.47; short-term debt: 33.8% and cash: 30.3% of total assets), and 70.6% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 82
Relative position
BE, all sectors
reference
Office administrative, office support and other business support activities (NACE 82)
about 37% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
29.4%
Return on assets
27.3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-08-2026, 17 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
17 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 8 January 2025, CaenenRx was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€29,851
Total assets
€101,570
Net result
€27,684
Working capital
€16,012

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €101,570
Fixed assets €51,251
Current assets €50,319
Equity and liabilities €101,570
Equity €29,851
Debt €71,719
Debt finances 70.6% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€45,360
Cash flow
€36,474
Current ratio
1.47
Debt to equity
2.40
ROE
92.7%
ROA
27.3%
Interest coverage
31.81
Debt ≤ 1 year
€34,306
Debt > 1 year
€37,413
Income taxes
€7,616

Peer companies

Historical observation

Of the 2,390 companies that looked in July 2024 the way this one looks now, 1.0% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
1.0% went bankrupt
1.9% stopped otherwise
97% still going

A further 0.4% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,390 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 44 lines
Balance sheet Code2025
Assets
Total assets20/58€101,570
Fixed assets21/28€51,251
Tangible fixed assets22/27€51,251
Furniture and vehicles24€3,282
Leasing and similar rights25€47,969
Current assets29/58€50,319
Amounts receivable within one year40/41€19,373
Trade receivables40€19,373
Cash at bank and in hand54/58€30,764
Deferred charges and accrued income490/1€182
Equity and liabilities
Total equity and liabilities10/49€101,570
Equity10/15€29,851
Contributions10/11€3,000
Reserves13€26,851
Distributable reserves133€26,851
Profit (loss) carried forward14€0
Amounts payable17/49€71,719
Amounts payable after more than one year17€37,413
Financial debts170/4€37,413
Amounts payable within one year42/48€34,306
Current portion of amounts payable after more than one year42€10,809
Trade debts44€1,817
Suppliers440/4€1,817
Taxes, remuneration and social security45€19,687
Taxes450/3€17,527
Remuneration and social security454/9€2,160
Other amounts payable47/48€1,994
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8,790
Other operating charges640/8€956
Gross operating margin9900€46,317
Operating profit (loss)9901€36,570
Financial income75/76B€156
Recurring financial income75€156
Financial charges65/66B€1,426
Recurring financial charges65€1,426
Profit (loss) for the period before taxes9903€35,299
Income taxes67/77€7,616
Profit (loss) for the period9904€27,684
Profit (loss) for the period to be appropriated9905€27,684
Appropriation of the result
Profit (loss) to be appropriated9906€27,684
Transfer to equity691/2€26,851
To the legal reserve6920€26,851
Profit to be distributed694/7€833
Return on contributions (dividend)694€833

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8,790
Other operating charges640/8€956
Gross operating margin9900€46,317
Operating profit (loss)9901€36,570
Financial income75/76B€156
Recurring financial income75€156
Financial charges65/66B€1,426
Recurring financial charges65€1,426
Profit (loss) for the period before taxes9903€35,299
Income taxes67/77€7,616
Profit (loss) for the period9904€27,684
Profit (loss) for the period to be appropriated9905€27,684
Line2025
Assets
Total assets20/58€101,570
Fixed assets21/28€51,251
Tangible fixed assets22/27€51,251
Furniture and vehicles24€3,282
Leasing and similar rights25€47,969
Current assets29/58€50,319
Amounts receivable within one year40/41€19,373
Trade receivables40€19,373
Cash at bank and in hand54/58€30,764
Deferred charges and accrued income490/1€182
Equity and liabilities
Total equity and liabilities10/49€101,570
Equity10/15€29,851
Contributions10/11€3,000
Reserves13€26,851
Distributable reserves133€26,851
Profit (loss) carried forward14€0
Amounts payable17/49€71,719
Amounts payable after more than one year17€37,413
Financial debts170/4€37,413
Amounts payable within one year42/48€34,306
Current portion of amounts payable after more than one year42€10,809
Trade debts44€1,817
Suppliers440/4€1,817
Taxes, remuneration and social security45€19,687
Taxes450/3€17,527
Remuneration and social security454/9€2,160
Other amounts payable47/48€1,994
Line2025
Profit (loss) for the period9904€27,684
+ Depreciation and write-downs630€8,790
Operating cash flow (approximation)€36,474

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
17-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 17 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
144 m²
Building footprint
82 m²
Volume, LiDAR
1,014 m³
Parcel 44804D2560/00R006, Flanders · tallest building 15.9 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
CaenenRx
Guldenspoorstraat 5, 9000 GentBusiness and other management consultancy
since 20252.370.096.713
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44804D2560/00R006 Flanders 144 m² 1 · 82 m² 15.9 m · 4 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 24,517 companies in sector 82990 we hold annual accounts for 9,415. 6,378 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded08-01-2025
Fiscal year end31-12
Activities, NACEBEL 2025
82990Other business support services
70200Business and other management consultancy
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID 0208:1018427348
Also 9925:BE1018427348
Registered 24-02-2026

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.